Investment
Features
FeesSafety
Academy
More
Pluang+

Gemini launches 2.1% APY staking for Hyperliquid's HYPE token, expanding institutional interest.

Protocol Fundamentals
28 Sep 2026
Crypto Briefing
View Source
Bullish
Gemini launches 2.1% APY staking for Hyperliquid's HYPE token, expanding institutional interest.

Gemini has introduced staking for Hyperliquid's native HYPE token, offering about 2.1% annual yield to most US customers except New York residents. Hyperliquid is a Layer 1 blockchain focused on perpetual futures trading, using a delegated proof-of-stake system where token holders delegate to validators who secure the network and share rewards. Currently, 44% of HYPE's total supply is staked, generating yields between 2.1% and 2.3% APY. Gemini joins Kraken and Grayscale in supporting HYPE staking, with Kraken offering up to 2.2% APY and Grayscale providing a related ETF with staking rewards included.

The story about Gemini launching staking for Hyperliquid's HYPE token is presented here with Pluang's market data for context. For readers following the cryptocurrency market, 10 out of 50 major cryptocurrencies rose while 39 fell today. Notable movers include DOT at Rp20.879 with a 7.93% decrease, AXS at Rp19.786 down 7.22%, and SUSHI at Rp4.488 down 7.19%, as of Sep 29, 2026 02:51 WIB.

More News

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...

Market News
Bearish
2 hours ago
Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...

Market News
Bullish
2 hours ago
Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...

Market News
Bullish
3 hours ago
Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...

Market News
Neutral
3 hours ago
Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App